Four Democratic attorneys general from California, New York, Massachusetts, and New Jersey have filed a petition with the FDA to revoke restrictive regulations on mifepristone, an abortion medication. They argue that these regulations are medically unnecessary, especially given the drug's safety record over the past 25 years. This push for greater access comes amid heightened scrutiny of mifepristone following the Supreme Court's overturning of Roe v. Wade. The FDA has announced a review of the drug, raising concerns among reproductive health advocates about potential new restrictions.
The FDA must follow the science and lift these unnecessary barriers that put patients at risk and push providers out of care.
A large body of research shows mifepristone, first approved more than two decades ago, is safe and effective.
Collection
[
|
...
]